Post by
davgro on Jan 14, 2025 2:40pm
WELL M&A Plans Seen Driving Strong Growth in 2025
January 14, 2025 14:27 ET (19:27 GMT)
Dow Jones Newswires
WELL Health Technologies is set to continue its acquisitive momentum in 2025, and TD Cowen's David Kwan thinks WELL's unannounced additions could be positive for the balance sheet. In a report, the analyst says that these could account for almost C$75 million in revenue and C$8-C$9 million in Ebitda, which would represent about 6% upside to TD's current forecasts.
Kwan says WELL's current M&A pipeline includes 12 letters-of-intent reflecting C$65 million in revenue and in-line Ebitda margins. "With a continued robust M&A pipeline, we believe WELL will remain active with its M&A program that should help it drive strong, profitable growth," Kwan says.